1
New treatment eliminates bladder cancer in 82% of patients
LOS ANGELES — A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had previously resisted treatment. In the majority of cases, the cancer disappeared after only three months of treatment…